2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2020-6-1-0-21959Genetics<strong>Contribution of rs11927381 polymorphism of the <em>IGF2BP2</em> gene to the pathogenesis of type 2 diabetes</strong><strong>Contribution of rs11927381 polymorphism of the <em>IGF2BP2</em> gene to the pathogenesis of type 2 diabetes</strong>AzarovaIuliia E.AzarovaIuliia E.azzzzar@yandex.ruKlyosovaElena Yu.KlyosovaElena Yu.ecless@yandex.ruSakaliSvetlana Yu.SakaliSvetlana Yu.s.sakali00@mail.ruKovalevAlexey P.KovalevAlexey P.okspk46@mail.ru20206100

Background: Pancreatic beta-cell dysfunction, along with the insulin resistance of peripheral tissues, is a key element in the pathogenesis of type 2 diabetes (T2D). In this regard, of considerable interest is the study of the role of polymorphisms of the genes directly involved in the work of the beta cells of the islets of Langerhans in the formation of susceptibility to the disease. The aim of the study: To study the relationship of the polymorphic variant of the gene encoding insulin like growth factor 2 mRNA binding protein 2, IGF2BP2, (T&gt;C, rs11927381) with the risk of developing T2D in the residents of the Kursk region. Materials and methods: The study included 559 patients with type 2 diabetes and 540 healthy volunteers. Genotyping of the IGF2BP2 gene polymorphism (T&gt;C, rs11927381) was performed using iPLEX technology on a genomic time-of-flight mass spectrometer MassArray Analyzer 4 (Agena Bioscience). Statistical analysis was performed with the use of the online program SNPStats. Results: The frequency of the C/C genotype was significantly higher in the group of patients with T2D compared with the control group (OR 1.75; 95% CI 1.25-2.44; P=0.0026). The association retained its significance after adjustment for sex, age and body mass index (OR 1.87; 95% CI 1.26-2.78; P=0.0054). A gender-stratified analysis showed that the identified association was typical only for men (OR 2.27; 95% CI 1.17-4.40; P=0.041), while in women it was not observed (P&gt;0.05). C/T and C/C genotypes were associated with a decrease in total cholesterol and low-density lipoproteins in patients with T2D (P&lt;0.05). Conclusion: The established association indicates the involvement of the IGF2BP2 gene in the formation of susceptibility to T2D. The studied variant of rs11927381 is also associated with lower levels of total cholesterol and low-density lipoproteins in type 2 diabetic patients that may account for the SNP effects on epigenetic markers, such as methylation and acetylation.

Background: Pancreatic beta-cell dysfunction, along with the insulin resistance of peripheral tissues, is a key element in the pathogenesis of type 2 diabetes (T2D). In this regard, of considerable interest is the study of the role of polymorphisms of the genes directly involved in the work of the beta cells of the islets of Langerhans in the formation of susceptibility to the disease. The aim of the study: To study the relationship of the polymorphic variant of the gene encoding insulin like growth factor 2 mRNA binding protein 2, IGF2BP2, (T&gt;C, rs11927381) with the risk of developing T2D in the residents of the Kursk region. Materials and methods: The study included 559 patients with type 2 diabetes and 540 healthy volunteers. Genotyping of the IGF2BP2 gene polymorphism (T&gt;C, rs11927381) was performed using iPLEX technology on a genomic time-of-flight mass spectrometer MassArray Analyzer 4 (Agena Bioscience). Statistical analysis was performed with the use of the online program SNPStats. Results: The frequency of the C/C genotype was significantly higher in the group of patients with T2D compared with the control group (OR 1.75; 95% CI 1.25-2.44; P=0.0026). The association retained its significance after adjustment for sex, age and body mass index (OR 1.87; 95% CI 1.26-2.78; P=0.0054). A gender-stratified analysis showed that the identified association was typical only for men (OR 2.27; 95% CI 1.17-4.40; P=0.041), while in women it was not observed (P&gt;0.05). C/T and C/C genotypes were associated with a decrease in total cholesterol and low-density lipoproteins in patients with T2D (P&lt;0.05). Conclusion: The established association indicates the involvement of the IGF2BP2 gene in the formation of susceptibility to T2D. The studied variant of rs11927381 is also associated with lower levels of total cholesterol and low-density lipoproteins in type 2 diabetic patients that may account for the SNP effects on epigenetic markers, such as methylation and acetylation.

type 2 diabetes mellitussingle nucleotide polymorphismIGF2BP2genetic predispositiontype 2 diabetes mellitussingle nucleotide polymorphismIGF2BP2genetic predispositionСписок литературыCho N, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice. 2018 Apr; 138:271-281. DOI: https://doi.org/10.1016/j.diabres.2018.02.023Dedov II, Shestakova MV, Vikulova OK, et al. [Diabetes mellitus in the Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017]. Diabetes mellitus. 2018;21(3):144-159. Russian. DOI: https://doi.org/10.14341/DM9686Shestakova MV, Sukhareva OYu. [Diagnostics and choice of method treatment of type 2 diabetes mellitus]. Clinical pharmacology and therapy. 2018;27(2):3-9. Russian.Buniello A, MacArthur JAL, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic acids research. 2018;47(D1):D1005-D1012. DOI: https://doi.org/10.1093/nar/gky1120Shah M, Vella A. What is type 2 diabetes? Medicine. 2014;42(12):687-691. DOI: https://doi.org/10.1016/j.mpmed.2014.09.013De Fronzo RA. From triumvirate to the ominous octet: а new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009 Apr;58(4):773-95. DOI: 10.2337/db09-9028Cook JP, Morris AP. Multi-ethnic genome-wide association study identifies novel locus for type 2 diabetes susceptibility. Eur. J. Hum. Genet. 2016;24(8):1175-1180. DOI: https://doi.org/10.1038/ejhg.2016.17World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org.; 1999.World Health Organization. Global report on diabetes: executive summary (No. WHO/NMH/NVI/16.3). WorldHealthOrganization; 2016.Azarova I, Bushueva O, Konoplya A, et al. Glutathione S-transferase genes and the risk of type 2 diabetes mellitus: Role of sexual dimorphism, gene&ndash;gene and gene&ndash;smoking interactions in disease susceptibility. J. Diabetes. 2018;10(5):398-407. DOI: https://doi.org/10.1111/1753-0407.12623Azarova YuE, Klyosova EYu, Konoplya AI. [The role of polymorphisms of glutamate-cysteine ligase in type 2 diabetes mellitus susceptibility in Kursk population]. Research Result. Medicine and Pharmacy. 2018;4(1):39-52. Russian. DOI: 10.18413/2313-8955-2018-4-1-39-52Jin T. Current understanding on role of the Wnt signaling pathway effector TCF7L2 in glucose homeostasis. Endocrine reviews. 2016 June;37(3):254-277. DOI: https://doi.org/10.1210/er.2015-1146Nguyen-Tu MS, da Silva XG, Leclerc I, et al. Transcription factor-7&ndash;like 2 (TCF7L2) gene acts downstream of the Lkb1/Stk11 kinase to control mTOR signaling, &beta; cell growth, and insulin secretion. Journal of Biological Chemistry. 2018;293(36):14178-14189. DOI: 10.1074/jbc.RA118.003613Takamoto I, Kubota N, Nakaya K, et al. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass. Diabetologia. 2014;57(3):542-553. DOI: https://doi.org/10.1007/s00125-013-3131-6Marselli L, Thorne J, Dahiya S, et al. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PloS one. 2010;5(7):11499. DOI: https://doi.org/10.1371/journal.pone.0011499Dai N, Zhao L, Wrighting D, et al. IGF2BP2/IMP2-deficient mice resist obesity through enhanced translation of Ucp1 mRNA and other mRNAs encoding mitochondrial proteins. Cell metab. 2015 Apr;21(4):609-621. DOI: https://doi.org/10.1016/j.cmet.2015.03.006Christodoulou MI, Avgeris M, Kokkinopoulou I, et al. Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk. Sci. Rep. 2019;9(1):1512. DOI: https://doi.org/10.1038/s41598-018-37856-1Livingstone C, Borai A. Insulin‐like growth factor‐II: its role in metabolic and endocrine disease. Clin. Endocrinol. 2014;80(6):773-781. DOI: https://doi.org/10.1111/cen.12446Rada-Iglesias A, Ameur A, Kapranov P, et al. Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. Genome research. 2008;18(3):380-392. DOI: 10.1101/gr.6880908Pajukanta P, Lilja HE, Sinsheimer JS, et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nature genetics. 2004;36(4):371-376. DOI: https://doi.org/10.1038/ng1320Naukkarinen J, Gentile M, Soro-Paavonen A, et al. USF1 and dyslipidemias: converging evidence for a functional intronic variant. Human molecular genetics. 2005 Sept;14(17):2595-2605. DOI: https://doi.org/10.1093/hmg/ddi294